Working… Menu

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01837862
Recruitment Status : Recruiting
First Posted : April 23, 2013
Last Update Posted : March 5, 2021
Janssen Pharmaceuticals
Information provided by (Responsible Party):
Julie Krystal, Northwell Health

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2022
Estimated Study Completion Date : April 2023